Type 2 & other diabetes

Associations of triglyceride glucose-body mass index with short-term mortality in critically ill patients with ischemic stroke

Cardiovasc DiabetolPublished Retrospective cohort study

Authors' conclusion

Elevated TyG-BMI is significantly associated with an increased risk of short-term all-cause mortality in patients with critically ill IS in the United States. This result provides compelling evidence to address the existing discrepancies in this research domain, indicating that the TyG-BMI could serve as a straightforward and efficient biomarker for identifying critically ill IS patients at high risk of mortality.

Study context

Population
Critically ill patients with ischemic stroke, eICU database (United States); mean age 68.41 ± 14.16 years, 47.50% male
Participants
1,362 patients
Exposure
High vs lower triglyceride glucose-body mass index (TyG-BMI)
Outcome
28-day mortality (hospital and ICU)
Follow-up
28 days
Methodological detailseICU database, multivariate Cox regression, restricted cubic splines
  • eICU database
  • Multivariate Cox regression
  • Restricted cubic splines

Main finding

As reported in the abstract

28-day hospital and ICU mortality, high TyG-BMI group

28-day hospital mortality, high TyG-BMI group (multivariate Cox)

HR = 1.734

P = 0.032

28-day ICU mortality, high TyG-BMI group (multivariate Cox)

HR = 2.337

p = 0.048

Observational data: associations, not effects.

Further findings

Nonlinear association of TyG-BMI with 28-day hospital mortality (restricted cubic splines (RCS))

Nonlinear positive correlation; inflection point TyG-BMI
380.37
Below inflection point, per 1-SD (≈25.5 units) increase
HR = 1.373, P = 0.015
Above 380.376, per 1-SD increase
HR = 0.121, P = 0.057
Log-likelihood ratio test
P = 0.004

Association of TyG-BMI with 28-day ICU mortality (RCS)

Significant positive linear correlation

Original publication

Associations of triglyceride glucose-body mass index with short-term mortality in critically ill patients with ischemic stroke. Cardiovasc Diabetol. Published 28 February 2025. doi:10.1186/s12933-025-02583-1

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.